Voxelotor is a pharmaceutical raw material that functions as a hemoglobin S polymerization inhibitor. It is investigated for use in the management of sickle cell disease through a novel mechanism distinct from other compounds in this area.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Voxelotor?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Enasidenib
pharmaceutical raw material
Acoramidis
pharmaceutical raw material
Olmesartan
pharmaceutical raw material
Olmesartan medoxomil
pharmaceutical raw material
The international HS code for Voxelotor (CAS 1446321-46-5) is 2933.39.
2933.39
2933 39 99
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
2-hydroxy-6-[[2-(2-propan-2-ylpyrazol-3-yl)-3-pyridinyl]methoxy]benzaldehyde
FWCVZAQENIZVMY-UHFFFAOYSA-N
CC(C)N1C(=CC=N1)C2=C(C=CC=N2)COC3=CC=CC(=C3C=O)O
Sourcing Voxelotor?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.